Barriers to medication adherence in self-care management of systemic lupus erythematosus patients: a systematic review
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20261438Keywords:
Systemic lupus erythematosus, Medication adherence, Barriers, ChallengesAbstract
Aim of the study was to explore stakeholder viewpoints on factors impending compliance to medication among individuals with systemic lupus erythematosus (SLE). An extensive search of literature was carried out in PubMed, Embase, and Scopus databases extending from January 2000 to January 2026. The review encompassed all qualitative, peer-reviewed articles on obstacles to drug compliance, published in English language. Two individual reviewers evaluated study quality using the critical appraisal skills programme (CASP) qualitative checklist. Enhancing transparency in reporting the synthesis of qualitative research (ENTREQ) guidelines was used to synthesize the qualitative information. A total of eleven studies were selected. Prominent patient level barriers encompassed insufficient knowledge of the disease condition, risks of non-compliance, forgetfulness, inadequate social support, and suboptimal health teaching. Challenges associated to the healthcare resources, includes availability, cost, and suitability, which were noted in many articles. Proposed solution in reviewed articles to combat these included forming support networks, using electronic alerts, physical therapy, and specialized elderly care units at community health centres, along with cultural contextual approaches to patient support. Customized strategies focused on individual needs should be created to enhance management in SLE cases.
References
Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2024.
Yu H, Nagafuchi Y, Fujio K. Prevalence and associated factors of medication nonadherence in Japanese patients with systemic lupus erythematosus. Lupus. 2020;29(14):1834-42.
Leung J, Baker EA, Kim AHJ. Exploring intentional medication non-adherence in patients with systemic lupus erythematosus: the role of physician-patient interactions. Rheumatol Adv Pract. 2021;5(1):rkaa078.
Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence. 2013;7:675-82. DOI: https://doi.org/10.2147/PPA.S29549
World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003. Available at: https://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf. Accessed on 15 February 2026.
Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982. DOI: https://doi.org/10.1136/bmjopen-2017-016982
Costedoat-Chalumeau N, Houssiau F, Izmirly P, Le Guern V, Navarra S, Jolly M, et al. Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From 6 Countries: Longitudinal Cohort Study. Arthritis Rheumatol. 2023;75(12):2195-206. DOI: https://doi.org/10.1002/art.42645
Feldman CH, Yazdany J, Guan H, Solomon DH, Costenbader KH. Medication Nonadherence is Associated with Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries with Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2015;67(12):1712-21. DOI: https://doi.org/10.1002/acr.22636
Tselios K, Gladman DD, Tomlinson G, Su J, Anderson N, Urowitz MB. Guideline adherence in the management of lupus: Key challenges and potential solutions. LupusHub. 2025. Available at: https://lupushub.com/medical-information/guideline-adherence-in-the-management-of-lupus-key-challenges-and-potential-solutions. Accessed on 15 February 2026.
Tong A, Flemming K, McInnes E, Oliver S, Craig J. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol. 2012;12:181. DOI: https://doi.org/10.1186/1471-2288-12-181
Critical Appraisal Skills Programme. CASP Qualitative Checklist. Oxford: CASP; 2018. Available at: https://casp-uk.net/casp-tools-checklists/. Accessed on 15 February 2026.
Sun K, Corneli AL, Dombeck C, Swezey T, Rogers JL, Criscione-Schreiber LG, et al. Barriers to taking medications for systemic lupus erythematosus: a qualitative study of racial minority patients, lupus providers, and clinic staff. Arthritis Care Res (Hoboken). 2022;74(9):1459-67. DOI: https://doi.org/10.1002/acr.24591
Tan QEC, Gao X, Ang WHD, Lau Y. Medication adherence: a qualitative exploration of the experiences of adolescents with systemic lupus erythematosus. Clin Rheumatol. 2021;40(7):2717-25. DOI: https://doi.org/10.1007/s10067-021-05583-0
Chambers SA, Raine R, Rahman A, Isenberg D. Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort. Rheumatology (Oxford). 2009;48(3):266-71. DOI: https://doi.org/10.1093/rheumatology/ken479
Garg S, Chewning B, Gazeley D, Gomez S, Kaitz N, Weber AC, et al. Patient and healthcare team recommended medication adherence strategies for hydroxychloroquine: results of a qualitative study informing intervention development. Lupus Sci Med. 2022;9(1):e000720. DOI: https://doi.org/10.1136/lupus-2022-000720
Sloan M, Naughton F, Harwood R, Sutton S, D'Cruz D, Direskeneli H, et al. Is it me? The impact of patient-physician interactions on lupus patients' psychological well-being, cognition and health-care-seeking behaviour. Rheumatol Adv Pract. 2020;4(2):rkaa037. DOI: https://doi.org/10.1093/rap/rkaa037
Farinha F, Freitas F, Águeda A, Cunha I, Barcelos A. Concerns of patients with systemic lupus erythematosus and adherence to therapy-a qualitative study. Patient Prefer Adherence. 2017;11:1213-9. DOI: https://doi.org/10.2147/PPA.S137544
Leung J, Baker EA, Kim AHJ. Exploring intentional medication non-adherence in patients with systemic lupus erythematosus: the role of physician-patient interactions. Rheumatol Adv Pract. 2021;5(1):rkaa078. DOI: https://doi.org/10.1093/rap/rkaa078
Mosley-Williams A, Lumley MA, Gillis M, Leisen J, Guice D. Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Rheum. 2002;47(6):630-8. DOI: https://doi.org/10.1002/art.10790
Julian LJ, Yelin E, Yazdany J, Panopalis P, Trupin L, Julian J, et al. Depression, medication adherence, and service utilization in systemic lupus erythematosus. Arthritis Rheum. 2009;61(2):240-6. DOI: https://doi.org/10.1002/art.24236
Herndon S, Corneli A, Dombeck C, Swezey T, Clowse ME, Rogers JL, et al. A qualitative study of facilitators of medication adherence in systemic lupus erythematosus: Perspectives from rheumatology providers/staff and patients. Lupus. 2024;33(2):137-44. DOI: https://doi.org/10.1177/09612033231225843
Emamikia S, Gentline C, Enman Y, Parodis I. How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study. J Clin Med. 2022;11(7):1857. DOI: https://doi.org/10.3390/jcm11071857
Downloads
Published
How to Cite
Issue
Section
